Double maintains 8 strategies that include SYK - Stryker Corp.
Current Value
$393.631 Year Return
Current Value
$393.631 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 84.50% | $4.62B | 0.4% |
JEPI | 71.22% | $40.99B | 0.35% |
FXH | 70.69% | $903.07M | 0.62% |
RSPH | 69.92% | $729.81M | 0.4% |
TDVG | 69.87% | $879.22M | 0.5% |
FDLO | 69.69% | $1.22B | 0.16% |
OUSA | 69.58% | $814.35M | 0.48% |
VIG | 68.62% | $92.27B | 0.05% |
QUS | 68.48% | $1.58B | 0.15% |
FTCS | 68.30% | $8.40B | 0.52% |
LGLV | 67.90% | $1.09B | 0.12% |
IYH | 67.89% | $2.73B | 0.39% |
JQUA | 67.86% | $6.38B | 0.12% |
USMV | 67.75% | $23.82B | 0.15% |
RSPA | 67.72% | $349.74M | 0.29% |
FHLC | 67.69% | $2.44B | 0.084% |
SPYV | 67.54% | $26.58B | 0.04% |
VHT | 67.53% | $15.35B | 0.09% |
IVE | 67.39% | $39.06B | 0.18% |
XHE | 67.38% | $166.72M | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -57.46% | $164.54M | 0.85% |
TAIL | -56.51% | $99.63M | 0.59% |
IVOL | -28.26% | $347.03M | 1.02% |
BTAL | -27.49% | $296.22M | 1.43% |
TPMN | -26.14% | $30.70M | 0.65% |
FTSD | -18.31% | $231.81M | 0.25% |
XONE | -15.34% | $625.28M | 0.03% |
CLIP | -14.95% | $1.51B | 0.07% |
FXY | -12.78% | $816.38M | 0.4% |
SHYM | -11.57% | $357.13M | 0.35% |
ULST | -9.78% | $654.75M | 0.2% |
SPTS | -9.58% | $5.80B | 0.03% |
CANE | -9.26% | $10.37M | 0.29% |
KCCA | -8.59% | $109.43M | 0.87% |
TBLL | -8.39% | $2.13B | 0.08% |
GBIL | -7.07% | $6.37B | 0.12% |
BILZ | -6.42% | $821.74M | 0.14% |
VGSH | -5.87% | $22.80B | 0.03% |
STPZ | -5.75% | $450.47M | 0.2% |
UTWO | -5.44% | $379.52M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSMW | -0.04% | $107.45M | 0.18% |
LDUR | -0.06% | $929.65M | 0.5% |
CTA | 0.21% | $1.06B | 0.76% |
VTIP | 0.57% | $15.33B | 0.03% |
OILK | -0.61% | $71.87M | 0.69% |
WEAT | -0.93% | $117.15M | 0.28% |
TFLO | 1.08% | $6.82B | 0.15% |
IBTH | -1.09% | $1.62B | 0.07% |
IBMN | 1.09% | $447.08M | 0.18% |
IBTJ | 1.11% | $688.19M | 0.07% |
STOT | -1.12% | $254.07M | 0.45% |
TDTT | 1.33% | $2.64B | 0.18% |
UUP | 1.37% | $201.63M | 0.77% |
USL | -1.44% | $42.23M | 0.85% |
ASHR | 1.49% | $1.91B | 0.65% |
UDN | -1.50% | $148.33M | 0.78% |
IEI | 1.68% | $15.48B | 0.15% |
COMT | 2.04% | $604.69M | 0.48% |
IBTI | -2.08% | $1.06B | 0.07% |
DBE | -2.21% | $52.20M | 0.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BSX | 68.97% | $153.32B | +36.16% | 0.00% |
ISRG | 67.15% | $193.76B | +24.33% | 0.00% |
MCO | 64.85% | $89.43B | +16.70% | 0.72% |
SPGI | 63.90% | $161.21B | +16.95% | 0.71% |
AVB | 60.37% | $28.76B | +0.52% | 3.41% |
LIN | 59.12% | $224.62B | +10.22% | 1.21% |
BN | 58.92% | $103.22B | +45.48% | 0.54% |
EQR | 58.68% | $25.33B | -1.21% | 4.10% |
CPAY | 58.52% | $23.76B | +26.07% | 0.00% |
MA | 58.44% | $509.89B | +25.29% | 0.50% |
ECL | 58.17% | $77.25B | +15.52% | 0.92% |
SPG | 57.41% | $54.13B | +11.86% | 5.01% |
BNT | 57.35% | $12.59B | +45.18% | 0.00% |
UDR | 57.32% | $13.44B | -0.07% | 4.20% |
FR | 57.21% | $6.54B | +3.72% | 3.31% |
MMSI | 57.18% | $5.53B | +8.92% | 0.00% |
STE | 56.98% | $23.44B | +9.60% | 0.96% |
HON | 56.96% | $153.77B | +12.61% | 1.86% |
V | 56.86% | $686.89B | +31.69% | 0.64% |
PLD | 56.77% | $100.50B | -4.40% | 3.64% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | -17.69% | $12.63B | -95.46% | 2.42% |
AGL | -12.10% | $989.35M | -60.10% | 0.00% |
MVO | -9.43% | $66.47M | -37.17% | 21.45% |
CPSH | -8.92% | $42.27M | +74.25% | 0.00% |
K | -8.58% | $27.76B | +41.17% | 2.85% |
HUSA | -8.12% | $19.66M | -19.53% | 0.00% |
UUU | -8.08% | $7.17M | +101.30% | 0.00% |
LXRX | -5.66% | $332.63M | -44.83% | 0.00% |
POAI | -5.15% | $7.45M | -17.40% | 0.00% |
SRRK | -4.64% | $3.38B | +357.53% | 0.00% |
MKTX | -3.70% | $8.22B | +9.03% | 1.38% |
DFDV | -3.29% | $300.56M | +2,130.16% | 0.00% |
RLX | -2.92% | $2.13B | +27.17% | 0.42% |
VSTA | -2.91% | $344.07M | +39.29% | 0.00% |
STG | -2.88% | $30.78M | -22.51% | 0.00% |
NEOG | -2.81% | $1.14B | -65.61% | 0.00% |
ALXO | -2.67% | $23.78M | -92.05% | 0.00% |
VRCA | -2.44% | $59.96M | -91.36% | 0.00% |
ZCMD | -2.34% | $29.55M | -8.59% | 0.00% |
GALT | -2.33% | $137.34M | +0.93% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYPR | 0.18% | $48.49M | +14.05% | 0.00% |
VSA | 0.44% | $8.67M | -19.04% | 0.00% |
MSIF | 0.51% | $769.47M | +36.17% | 7.61% |
CYCN | 0.51% | $10.59M | +46.35% | 0.00% |
ALHC | -0.64% | $2.69B | +71.20% | 0.00% |
DG | 0.81% | $25.41B | -7.95% | 2.05% |
SLE | 0.86% | $4.57M | -84.82% | 0.00% |
DQ | 0.96% | $1.18B | +11.88% | 0.00% |
IMNN | 1.02% | $16.26M | -34.16% | 0.00% |
SAVA | 1.12% | $97.10M | -81.34% | 0.00% |
CCRN | -1.13% | $429.13M | -3.89% | 0.00% |
TDUP | -1.13% | $895.13M | +358.79% | 0.00% |
OCFT | -1.36% | $267.49M | +332.74% | 0.00% |
PRA | 1.36% | $1.17B | +89.68% | 0.00% |
AQB | 1.38% | $2.96M | -53.35% | 0.00% |
CRVO | 1.48% | $48.39M | -64.97% | 0.00% |
GORV | 1.49% | $27.07M | -91.17% | 0.00% |
GHG | 1.52% | $162.90M | -2.79% | 0.00% |
CNK | 1.62% | $3.47B | +41.29% | 0.53% |
AIFU | -1.75% | $6.79B | +102.19% | 0.00% |
SeekingAlpha
Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term dilution. Read the full GMED stock analysis.
MarketWatch
Stryker Corp. stock underperforms Wednesday when compared to competitors
Yahoo
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, July 31, 2025, to d
Yahoo
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
Yahoo
Carlin will take leadership of the segment as Stryker sees growth in robotic surgeries.
Yahoo
JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.